BioGentech Agrees To Name Change As Part of Trademark Settlement
In November, Biogen sued BioGentech for trademark infringement and unfair competition in the U.S. District Court for the District of Massachusetts.
Under the terms of the settlement, BioGentech will be prohibited from using any phonetic equivalent of BioGentech, the company revealed in a Form 8K filed with the Securities and Exchange Commission.
BioGentech will also discontinue use...
To view the full article, register now.